跳至主要内容
临床试验/EUCTR2009-015744-42-GB
EUCTR2009-015744-42-GB进行中(未招募)不适用

Randomized open label study of oral versus intravenous antibiotic treatment for bone and joint infections requiring prolonged antibiotic treatment: Preliminary study in a single centre. - Oral versus intravenous antibiotics for bone and joint infection

Oxford Radcliffe Hospitals Trust0 个研究点目标入组 200 人开始时间: 2009年9月11日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Is willing and able to give informed consent for participation in the study.
  • Has a bone and joint infection* in one of the following categories;
  • 1.Native osteomyelitis (i.e., bone infection without metalwork) where a prolonged (i.e., 6 week) course of antibiotics is indicated (i.e., excluding limited superficial disease, or patients where curative amputations or excisions of all infected bone have been carried out).
  • 2.Native joint septic arthritis treated by excision arthoplasty, with or without intended 2-stage revision.
  • 3.Diabetic foot infection with proven or presumptive osteomyelitis where a prolonged (i.e. 6 week) course of antibiotics is indicated (i.e., excluding limited superficial disease or patients where curative excision of all infected bone has been carried out).
  • 4.Prosthetic joint associated infection treated by debridement and retention
  • 5.Orthopaedic device associated infection treated by debridement and retention
  • 6.Prosthetic joint associated infection where a 2 stage revision is planned, randomizing the patient after the 1st stage (i.e., after excision of the infected prosthesis).
  • 7.Prosthetic joint associated infection treated by 1 stage revision
  • 8.Removal of orthopaedic device or bone graft for infection (excluding limited superficial disease requiring short courses of antibiotics).
  • 9. Discitis/ spinal osteomyelitis/ epidural abscess
  • Has had at least 48 hours, but not more than 7 days, of IV antibiotic therapy already given after definitive surgical management*.
  • Has a clinical diagnosis of bacterial infection (caused by any organism excepting mycobacteria).
  • Has a life expectancy > 1 year.
  • Is clinically stable in the opinion of the study clinicians, has no further interventions to treat acute infection required or planned.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Has Staph aureus bacteraemia found on blood cultures taken for clinical indications. (No study-required blood cultures will be taken). Patients with Staph aureus bacteraemia often require longer courses of intravenous antibiotics, and may be the subject of a separate randomized trial.
  • Has suspected bacterial endocarditis, based on clinical, microbiological or imaging studies. (No study-required echocardiograms will be requested). Patients with endocarditis are considered to need longer courses of intravenous antibiotics.
  • Has suspected mediastinial infection
  • Has suspected central nervous system infection
  • Is unlikely to comply with trial requirements in the opinion of the investigator.
  • Has an infection for which there is no suitable antibiotic choices to permit randomization between the two arms of the trial
  • Has a non-bacterial (i.e., mycobacterial, fungal, parasitic or viral) infection based on clinical, histological or microbiological findings at site of infection.
  • Previously enrolled in the trial.
  • Is receiving an investigational medical product as part of another clinical trial.

研究者

发起方
Oxford Radcliffe Hospitals Trust

相似试验